MedReleaf Australia interim managing director Kristin Viccars has joined the board of Medicinal Cannabis Industry Australia (MCIA).

He replaces former MedReleaf CEO and founding MCIA board member Russell Harding who has stood down following the firm’s sale to Aurora Cannabis in February.

Kristin Viccars (Photo: MCIA)

Viccars has more than 15 years’ experience working in a diverse range of businesses and industries both locally and abroad and holds an executive MBA and graduate diploma in business law.

He said: “I am honoured to be provided the opportunity to contribute to the growth and progress of the cannabis industry in Australia by joining the MCIA board and collaborating with this esteemed group. Thank you to the MCIA for welcoming me.”

Harding added: “Having known Kristin for many years, appointing him to the COO role at MedReleaf Australia where his endeavours had an immediate impact, I am delighted that MCIA has accepted him as my replacement on the board of this critically important organisation at this challenging period in our industry.”

Meanwhile, MCIA chair Peter Koetsier paid tribute to Harding: “The board would like to extend its heartfelt thanks to Russell for his contribution to MCIA over the past six years [and] wishes [him] all the best as he focuses on the next stages.”

MCIA recently called for nominations to expand the board and is currently reviewing applications.

Prior to launching Cannabiz, Martin was co-founder and CEO of Asia-Pac’s leading B2B media and marketing information brand Mumbrella, overseeing its sale to Diversified Communications in 2017. A journalist...

Leave a comment